Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-13

Clinical Trial Update: The Contact-CTI Study: Use of Tissue Contact Data to Guide Atrial Flutter Ablation [Phase 4]

View source ↗

Summary

The Contact-CTI study evaluated using tissue contact data to guide atrial flutter ablation in a Phase 4 trial, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oxford University Hospitals NHS Trust | Conditions: Atrial Flutter | Phase 4 | Status: COMPLETED